Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Intraperitoneal chemotherapy
Email alerts
Intraperitoneal chemotherapy
Paclitaxel maintenance chemotherapy following intraperitoneal chemotherapy for ovarian cancer
W. R.
Robinson
,
N.
Davis
,
A. S.
Rogers
International Journal of Gynecologic Cancer
Aug 2008,
18
(5)
891-895;
DOI:
10.1111/j.1525-1438.2007.01118.x
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature
A.
Gadducci
,
P. F.
Conte
International Journal of Gynecologic Cancer
Aug 2008,
18
(5)
943-953;
DOI:
10.1111/j.1525-1438.2007.01163.x
Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer
S. B.
Howell
International Journal of Gynecologic Cancer
Feb 2008,
18
(Suppl 1)
20-25;
DOI:
10.1111/j.1525-1438.2007.01099.x
Can carboplatin replace cisplatin for intraperitoneal use?
K.
Fujiwara
International Journal of Gynecologic Cancer
Feb 2008,
18
(Suppl 1)
29-32;
DOI:
10.1111/j.1525-1438.2007.01101.x
Strategies to examine new compounds for intraperitoneal use in ovarian cancer
M.
Markman
International Journal of Gynecologic Cancer
Feb 2008,
18
(Suppl 1)
33-35;
DOI:
10.1111/j.1525-1438.2007.01102.x
What is the optimal approach to the administration of intraperitoneal chemotherapy in ovarian cancer?
M.
Markman
International Journal of Gynecologic Cancer
Feb 2008,
18
(Suppl 1)
36-39;
DOI:
10.1111/j.1525-1438.2007.01103.x
Retraction of an intraperitoneal chemotherapy port: a case report and literature review
M.
Pendergrass
,
M. E.
Gordinier
,
L. P.
Parker
,
D. S.
Metzinger
,
C. W.
Helm
International Journal of Gynecologic Cancer
Sep 2007,
17
(5)
1131-1133;
DOI:
10.1111/j.1525-1438.2007.00910.x
Ototoxicity after intraperitoneal chemotherapy: a case report
L.
Nieves
,
J.
Currie
,
J.
Hoffman
,
J. I.
Sorosky
International Journal of Gynecologic Cancer
Sep 2007,
17
(5)
1133-1135;
DOI:
10.1111/j.1525-1438.2007.00940.x
Principles and practice of intraperitoneal chemotherapy for ovarian cancer
K.
Fujiwara
,
D.
Armstrong
,
M.
Morgan
,
M.
Markman
International Journal of Gynecologic Cancer
Jan 2007,
17
(1)
1-20;
DOI:
10.1111/j.1525-1438.2007.00809.x
Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity
C. W.
Helm
,
C. R.
Toler
,
R. S.
Martin
,
M. E.
Gordinier
,
L. P.
Parker
,
D. S.
Metzinger
,
R. P.
Edwards
International Journal of Gynecologic Cancer
Jan 2007,
17
(1)
204-209;
DOI:
10.1111/j.1525-1438.2006.00751.x
Pages
« first
‹ previous
1
2
3
4
next ›
last »
Special collections
Editor's choice
(187)
Guidelines, Recommendations and Consensus Statements
IJGC
Case Study
(17)
Cervical Cancer
(20)
Clinical Trial
(107)
Corners of the World
(23)
Endometrial Cancer
Fertility and Pregnancy
Lay summaries
(1)
Lead articles
(13)
Ovarian Cancer
(35)
Palliative Care
Perioperative Care
Preinvasive Disease
(1)
Review
(28)
Surgical Outcomes
Uterine Cancer
(16)
Video Article
(176)
Vulvar Cancer
(2)
Open access
(266)
Press releases
(4)